Denali Therapeutics Ratios (2022-2026) | DNLI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2022	Jun2022	Sep2022	Dec2022	Jun2023	Sep2023	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Profitability
Gross Margin (Quarter)													97.42%
EBT Margin (Quarter)													-3,622.45%
EBIT Margin (Quarter)													-3,622.11%
EBITDA Margin (Quarter)													-3,622.11%
Operating Margin (Quarter)													-3,622.11%
Net Margin (Quarter)													-3,622.45%
FCF Margin (Quarter)													-2,713.85%
Efficiency
Assets Average (Quarter)													1,211.99M
Invested Capital (Quarter)	2.71M		1.44M	4.39M			5.68M	9.34M	8.54M	6.99M	5.63M	5.62M
Asset Utilization Ratio (Quarter)													0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)													-43.51
Debt Ratio (Quarter)	0.00		0.00	0.00
Times Interest Earned (Quarter)													-43.51
Valuation
Enterprise Value (Quarter)													-710.47M
Return Ratios
Return on Sales (Quarter)													-0.36%
Return on Capital Employed (Quarter)													-48.37%
Return on Invested Capital (Quarter)		-1.07%	-0.91%	-0.54%	-0.28%	-0.33%
Return on Assets (Quarter)													0.00%